Slingshot Therapeutics
PrivateLast Round
Accelerator
Nov 13, 2024
Total Funding Raised
$15.89M
Company Overview
Slingshot Therapeutics is a biotechnology company that operates as a medicines accelerator to identify, de-risk, and advance early-stage therapeutic programmes from academic research institutions toward clinical development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Slingshot Therapeutics Comparables
Compare Slingshot Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argobio | 80% | |
| BlueBee | 71% | |
| Johnson & Johnson | 69% | |
Slingshot Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 13, 2024 |
Slingshot Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Grew 43% QoQ from 7 to 10 employees.
- Nov 13, 2024
$16M round led by Syncona.
Slingshot Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Slingshot Therapeutics's valuation, stock price, and market status.